Optimising antithrombotic therapy after ACS and PCI.
Aspirin
Dual antiplatelet therapy
P2Y(12) receptor inhibitor
Trade-off
Journal
Vascular pharmacology
ISSN: 1879-3649
Titre abrégé: Vascul Pharmacol
Pays: United States
ID NLM: 101130615
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
12
07
2023
revised:
31
08
2023
accepted:
11
09
2023
pubmed:
18
9
2023
medline:
18
9
2023
entrez:
17
9
2023
Statut:
ppublish
Résumé
Dual antiplatelet therapy, combining aspirin with a platelet P2Y
Identifiants
pubmed: 37717709
pii: S1537-1891(23)00088-5
doi: 10.1016/j.vph.2023.107228
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107228Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Davide Capodanno declares speaker's honoraria from Sanofi, Terumo. Daiichi Sankyo and institutional payments from Medtronic.